Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

CardioGenesis Closes Private Placement With Wisconsin Investment Board

Photonics.com
Dec 2001
FOOTHILL RANCH, Calif., Dec. 28 -- CardioGenesis Corp. has announced the closing of a $2.0 million private placement of its common stock with the State of Wisconsin Investment Board. The private placement involved 2,222,225 shares of CardioGenesis common stock at a fixed price and terms agreed in mid-December.

CardioGenesis is a medical device company specializing in the treatment of cardiovascular disease and is the leader in products that stimulate cardiac angiogenesis. The company's Holmium:YAG laser system and disposable fiber optic accessories are used to perform an FDA-cleared surgical procedure known as transmyocardial revascularization to treat patients suffering from angina.


News & Features

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.